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Abstract
The genetic background of childhood body mass index (BMI), and the extent to which the
well-known associations of childhood BMI with adult diseases are explained by shared
genetic factors, are largely unknown. We performed a genome-wide association study
meta-analysis of BMI in 61,111 children aged between 2 and 10 years. Twenty-five indepen-
dent loci reached genome-wide significance in the combined discovery and replication anal-
yses. Two of these, located near NEDD4L and SLC45A3, have not previously been
reported in relation to either childhood or adult BMI. Positive genetic correlations of child-
hood BMI with birth weight and adult BMI, waist-to-hip ratio, diastolic blood pressure and
type 2 diabetes were detected (Rg ranging from 0.11 to 0.76, P-values <0.002). A negative
genetic correlation of childhood BMI with age at menarche was observed. Our results sug-
gest that the biological processes underlying childhood BMI largely, but not completely,
overlap with those underlying adult BMI. The well-known observational associations of BMI
in childhood with cardio-metabolic diseases in adulthood may reflect partial genetic overlap,
but in light of previous evidence, it is also likely that they are explained through phenotypic
continuity of BMI from childhood into adulthood.
Author summary
Although twin studies have shown that body mass index (BMI) is highly heritable, many
common genetic variants involved in the development of BMI have not yet been identi-
fied, especially in children. We studied associations of more than 40 million genetic vari-
ants with childhood BMI in 61,111 children aged between 2 and 10 years. We identified
25 genetic variants that were associated with childhood BMI. Two of these have not been
implicated for BMI previously, located close to the genes NEDD4L and SLC45A3. We also
show that the genetic background of childhood BMI overlaps with that of birth weight,
adult BMI, waist-to-hip-ratio, diastolic blood pressure, type 2 diabetes, and age at menar-
che. Our results suggest that the biological processes underlying childhood BMI largely
overlap with those underlying adult BMI. However, the overlap is not complete.
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Additionally, the genetic backgrounds of childhood BMI and other cardio-metabolic phe-
notypes are overlapping. This may mean that the associations of childhood BMI and later
cardio-metabolic outcomes are partially explained by shared genetics, but it could also be
explained by the strong association of childhood BMI with adult BMI.
Introduction
Childhood obesity is a major public health problem with impact on health in both the short
and the long term [1]. Besides the well-established lifestyle and behavioral factors, genetics
influence the risk of obesity, with reported heritability estimates from twin studies for body
mass index (BMI) ranging from 40 to 70% [2,3]. An estimated 17 to 27% seems to be explained
by common variants [4–6]. Large genome-wide association studies (GWAS) have identified
941 loci associated with adult BMI, accounting for 5% of the phenotypic variation [7]. Less is
known about the genetic background of childhood BMI. A previous GWAS of BMI among
35,668 children identified 15 associated loci, accounting for 2% of the phenotypic variance [8].
Of these loci, 12 were also associated with adult BMI [9,10]. The remaining 3 identified genetic
loci, specifically associated with childhood BMI, suggest possible age-specific differences
between the two stages of life or could indicate stronger effects for these genetic loci in child-
hood BMI than in adult BMI [11–13]. Thus far, most common variants explaining the genetic
variability of childhood BMI remain undetected. It is well known that obesity in early-life
tends to track into later life [14]. Furthermore, childhood obesity has been associated with a
lower age at menarche and with non-communicable diseases in later life, including hyperten-
sion, dyslipidemia, type 2 diabetes, neurodegenerative disease and asthma [15–19]. Findings
from recent studies suggest a shared genetic background for BMI in childhood and adulthood
[8,20,21]. To which extent the associations of childhood BMI with common adult diseases are
genetically explained, has not been explored in detail.
We aimed to study the genetic background of childhood BMI by performing a two-stage
GWAS meta-analysis consisting of 41 studies with a total sample size of 61,111 children of
European ancestry. We also examined the genetic correlations of childhood BMI with anthro-
pometric, cardio-metabolic, respiratory, neurocognitive and endocrinological traits in adults,
using GWAS summary statistics from various consortia.
Results
Identification of genome-wide significant loci for childhood BMI
Sex- and age-adjusted Standard Deviation Scores (SDS) were created for BMI at the latest time
point (oldest age, if multiple measurements were available) between 2 and 10 years using the
same software and external reference across all studies (LMS growth; Pan H, Cole TJ, 2012;
http://www.healthforallchildren.co.uk). Individual study characteristics are shown in S1 Table.
The discovery meta-analysis included data from 26 studies (Ndiscovery = 39,620) with data
imputed to the 1000 Genomes Project or The Haplotype Reference Consortium (HRC). We
performed a fixed-effects inverse variance-weighted meta-analysis and performed conditional
analyses based on summary-level statistics and Linkage Disequilibrium (LD) estimation
between SNPs in Genome-wide Complex Trait Analysis (GCTA) to select independently asso-
ciated SNPs at each locus on the basis of conditional P-values [22]. Seventeen independent
SNPs reached genome-wide significance (P-values <5 × 10−8) and thirty SNPs showed sugges-
tive association with childhood BMI (P-values >5 × 10−8 and<5 × 10−6). A Manhattan plot of
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the discovery meta-analysis is shown in Fig 1. No evidence of inflation due to population strat-
ification or cryptic relatedness or other confounders was observed (genomic inflation factor
(lambda) = 1.05; LD-score regression intercept = 1.0) (S1 Fig) [23]. All 47 independent SNPs
identified in the discovery meta-analysis were taken forward for analysis in 15 replication
cohorts (Nreplication = 21,491) and results of the two stages were then combined. Results of the
discovery, replication and combined meta-analyses are shown in Table 1 and S2 Table and S3
Table. Results of the discovery analysis for SNPs with P-values <5 × 10−6 are shown in S4
Table. As the replication stage might lack power to replicate SNPs from the discovery analysis,
we consider the joint analysis as the primary analysis.
In total, 25 loci achieved genome-wide significance in the combined meta-analysis. We
defined a SNP as representing a known BMI-locus if it was within 500 kb of and in LD (r2�
0.2) with a previously reported BMI-associated signal. Of the 25 SNPs, two were novel and had
not been previously associated with BMI in either adults or children: rs1094647 near SLC45A3
and rs184566112 near NEDD4L. Per additional risk allele (G, allele frequency = 0.55) of
rs1094647 (SLC45A3), childhood BMI increased by 0.04 SDS (Standard Error (SE) = 0.01, P-
value = 7.20 × 10−10), equal to 0.09 kg/m2. Per additional risk allele (A, allele frequency = 0.84)
of rs184566112 (NEDD4L), childhood BMI increased by 0.06 SDS (SE = 0.01; P-
value = 4.24 × 10−8), equal to 0.11 kg/m2. Regional plots of the 2 novel SNPs are shown in Fig 2.
Despite the fact that these novel SNPs were not associated with either childhood or adult
BMI previously, they have been reported to be associated with other anthropometric pheno-
types. Rs1094647 (SLC45A3) has been associated with both height and whole-body fat-free
mass in adulthood [24–26]. Additionally, rs708724, which is in high LD with rs1094647 (r2 =
0.70) was associated with adult weight [24–26]. Rs184566112 (NEDD4L) is located in the same
Fig 1. Manhattan plot of results of the discovery meta-analysis of 26 single study GWAS. On the x-axis the chromosomes are shown. On the y-
axis the–log 10 of the P-value is shown. Novel SNPs are shown in green. Independent SNPs are shown in blue. Known SNPs are shown in black. The
genome wide significance cutoff of 5 × 10−8 is represented by the grey dotted line.
https://doi.org/10.1371/journal.pgen.1008718.g001
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Table 1. Results of the discovery, replication and combined analyses for the 47 loci with P-values<5 x 10−6 in the discovery phase.
SNP CHR Position Nearest gene EA/
non_EA
P-value
discovery
P-value
replication
EAFa Beta
combined
SE
combined
P-value
combined
rs11676272b,c 2 25141538 ADCY3 G/A 2.37 x 10−21 1.88 x 10−10 0.46 0.071 0.006 3.79 x 10−30
rs7138803b,c 12 50247468 BCDIN3D A/G 7.12 x 10−20 7.39 x 10−12 0.37 0.072 0.006 4.23 x 10−30
rs939584b,c,d 2 621558 TMEM18 T/C 8.85 x10-26 2.52 x 10−6 0.83 0.092 0.008 3.73 x 10−29
rs17817449b,c 16 53813367 FTO G/T 1.69 x 10−17 3.21 x 10−11 0.40 0.069 0.006 2.98 x 10−27
rs12042908b,c 1 74997762 FPGT-TNNI3K,
TNNI3K
A/G 2.77 x 10−14 2.01 x 10−12 0.46 0.064 0.006 6.37 x 10−25
rs543874b,c 1 177889480 SEC16B G/A 1.61 x 10−15 6.96 x 10−8 0.19 0.075 0.008 6.02 x 10−22
rs56133711b 11 27723334 BDNF A/G 2.00 x 10−10 3.69 x 10−6 0.24 0.056 0.007 3.75 x 10−15
rs2076308b,c 6 50791640 TFAP2B C/G 1.59 x 10−12 0.01 0.19 0.058 0.008 3.07 x 10−13
rs4477562b,c,e 13 54104968 LINC00558 T/C 8.29 x 10−13 0.01 0.13 0.065 0.009 5.81 x 10−13
rs571312b,c 18 57839769 MC4R A/C 2.00 x 10−10 4.84 x 10−4 0.23 0.052 0.007 8.80 x 10−13
rs12641981b,c 4 45179883 GNPDA2 T/C 4.19 x 10−8 7.12 x 10−6 0.44 0.045 0.006 1.29 x 10−12
rs62107261f 2 422144 FAM150B T/C 3.17 x 10−7 6.64 x 10−6 0.95 0.121 0.018 9.93 x 10−12
rs114285994b 16 19935763 GPRC5B G/A 1.41 x 10−10 5.98 x 10−3 0.87 0.063 0.009 1.11 x 10−11
rs144376234b,c 1 110114504 GNAI3 T/C 1.35 x 10−8 2.21 x 10−3 0.04 0.111 0.017 1.38 x 10−10
rs1094647 1 205655378 SLC45A3 G/A 2.46 x 10−6 7.45 x 10−5 0.55 0.038 0.006 7.20 x 10−10
rs76227980f 18 58036384 MC4R C/T 1.71 x 10−6 1.19 x 10−4 0.98 0.140 0.023 8.68 x 10−10
rs13107325b 4 103188709 SLC39A8 T/C 3.51 x 10−8 4.84 x 10−3 0.07 0.082 0.014 1.38 x 10−9
rs62500888c 8 28061823 ELP3 A/G 6.91 x 10−10 0.09 0.57 0.037 0.006 1.81 x 10−9
rs114670539c 2 207064335 GPR1 T/C 3.16 x 10−8 0.01 0.05 0.088 0.015 1.92 x 10−9
rs61765651b 1 72754314 NEGR1 C/T 9.50 x 10−9 0.03 0.83 0.047 0.008 4.99 x 10−9
rs7719067b 5 153538241 GALNT10 A/G 3.96 x 10−7 4.36 x 10−3 0.43 0.036 0.006 6.54 x 10−9
rs11030391f 11 28644626 METTL15 A/G 4.73 x 10−7 6.49 x 10−3 0.63 0.036 0.006 1.51 x 10−8
rs184566112 18 55943926 NEDD4L A/T 4.40 x 10−6 1.24 x 10−3 0.84 0.057 0.011 4.24 x 10−8
rs116664060 6 31592524 PRRC2A C/G 3.03 x 10−6 3.28 x 10−3 0.18 0.049 0.009 4.63 x 10−8
rs11215427c 11 115093438 CADM1 G/C 1.25 x 10−7 0.05 0.74 0.039 0.007 4.64 x 10−8
rs1336980c 9 129377855 LMX1B C/G 6.61 x 10−7 0.03 0.36 0.033 0.006 1.17 x 10−7
rs146823532f 1 74979126 FPGT-TNNI3K,
TNNI3K
A/G 4.09 x 10−7 0.03 0.97 0.114 0.022 1.33 x 10−7
rs79386556 13 71229046 LINC00348 A/G 1.84 x 10−6 0.04 0.04 0.095 0.019 4.83 x 10−7
rs9942489 6 35323709 PPARD A/T 3.62 x 10−6 0.02 0.04 0.081 0.016 5.56 x 10−7
rs17086809 9 86708695 RMI1 C/T 3.06 x 10−6 0.05 0.33 0.038 0.007 9.30 x 10−7
rs80332495 5 19191677 CDH18 A/G 3.78 x 10−7 0.26 0.94 0.090 0.019 1.14 x 10−6
rs4594227 15 84497207 ADAMTSL3 A/G 4.46 x 10−6 0.07 0.56 0.030 0.006 1.75 x 10−6
rs2457463 10 70315687 TET1 G/T 1.79x 10−7 0.43 0.04 0.159 0.034 2.69 x 10−6
rs11865086b 16 30130493 MAPK3 C/A 2.23 x 10−7 0.47 0.53 0.029 0.006 3.31 x 10−6
rs1565356 6 34046065 GRM4 C/A 1.76 x 10−6 0.25 0.92 0.057 0.012 4.01 x 10−6
rs2952863b 4 130759647 C4orf33 T/G 3.10 x 10−6 0.15 0.30 0.031 0.007 4.27 x 10−6
rs2358954 12 66379504 HMGA2 T/G 3.07 x 10−6 0.17 0.68 0.031 0.007 4.77 x 10−6
rs7652876 3 179831733 PEX5L A/C 3.22 x 10−6 0.19 0.25 0.033 0.007 6.93 x 10−6
rs4923207 11 24757325 LUZP2 T/G 1.07 x 10−6 0.86 0.81 0.040 0.009 7.05 x 10−6
rs7757288 6 55205502 GFRAL G/A 6.64 x 10−7 0.47 0.39 0.028 0.006 1.03 x 10−5
rs6876477 5 50878621 ISL1 A/T 3.03 x 10−6 0.35 0.76 0.032 0.007 1.31 x 10−5
rs28599560 5 91791853 FLJ42709 A/G 3.99 x 10−7 0.85 0.61 0.027 0.006 3.48 x 10−5
rs117281273 8 42981400 SGK196 C/G 2.17 x 10−7 0.94 0.97 0.081 0.020 3.48 x 10−5
rs9695734 9 96407983 PHF2 C/T 1.12 x 10−6 0.81 0.84 0.035 0.009 4.99 x 10−5
rs72833479 17 45960449 SP2 A/G 7.96 x 10−7 0.99 0.25 0.029 0.007 6.54 x 10−5
(Continued)
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region as rs6567160 (distance = 448 kb, r2 <0.2), previously associated with adult body fat
[27]. In the current study, we did not observe evidence for association between rs184566112
(NEDD4L, effect allele = G, allele frequency = 0.84) and body fat percentage measured by Dual
energy X-ray Absorptiometry (age range 24 to 120 months) in 2,698 children from 4 cohorts
(0.03 SDS (SE = 0.04, P-value = 0.51)). Individual study characteristics of studies with data on
body fat percentage are shown in S5 Table. No evidence of association with childhood obesity
was found for the two novel SNPs (P-values >0.11) [28].
We additionally identified 2 independent SNPs (METTL15 and PRRC2A) within 500 kb of
previously reported SNPs associated with adult BMI, but only in weak LD with prior reported
signals (r2 <0.2). Similarly, we found 2 independent SNPs in regions that are known for both
childhood and adult BMI (FAM150B and MC4R) [7,8,10]. Regional plots of the 4 independent
SNPs at known loci are shown in S2 Fig. Of the remaining 19 SNPs, 6 mapped to loci previ-
ously associated with adult BMI (BDNF, GPRC5B, SLC39A8, NEGR1, GALNT10, and
CADM1), 2 mapped to loci previously associated with childhood BMI only (ELP3 and GPR1)
and 11 SNPs mapped to loci known to be associated with both adult and childhood BMI
(ADCY3, BCDIN3D, TMEM18, FTO, FPGT-TNNI3K/TNNI3K, SEC16B, TFAP2B, LINC00558,
MC4R, GNPDA2, and GNAI3) [7,8,10].
Overall, there was low heterogeneity between studies for the 25 SNPs, except for FTO (S2
Table) [29]. The broad age range included in the discovery meta-analysis of this study may
conceal age-specific effects. Therefore, we performed a sensitivity analysis excluding studies of
children aged<6 years (remaining Nsensitvity analysis = 55,354), which showed similar results (S6
Table) [30]. Additionally, we ran a sensitivity analysis excluding case-control studies and one
excluding studies with a sample size <n = 500, showing similar results (S7 Table).
Functional characterization
We used several strategies to gain insight into the functional characterization of the 25 SNPs
leading the association signals with childhood BMI. A summary of relevant information from
all strategies can be found in S8 Table.
First, we examined gene expression profiles of the nearest genes to the 25 SNPs from the
combined meta-analysis with GTEx v7 in 53 tissues, using the tool FUMA [3,31]. We found
differential expression of the 25 nearest genes in brain and salivary gland. In a second analysis
of gene expression profiles in GTEx, we considered all genes in a region of 500 kb to either
Table 1. (Continued)
SNP CHR Position Nearest gene EA/
non_EA
P-value
discovery
P-value
replication
EAFa Beta
combined
SE
combined
P-value
combined
rs142367753 2 128938956 UGGT1 C/G 4.03 x 10−6 0.24 0.98 0.088 0.027 1.34 x 10−3
rs6896578 5 76423090 ZBED3-AS1 C/T 3.52 x 10−6 0.17 0.84 0.025 0.009 4.1 x 10−3
CHR, chromosome; EA, effect allele; EAF, effect allele frequency; SE, standard error.
Bolded P-values indicate genome-wide significance in the combined analysis.
Detailed information on beta and SE of the discovery and replication stage separately can be found in S2 Table
a From combined analysis
b Locus previously reported for adult BMI
c Locus previously reported for childhood BMI
d Locus previously reported for adult body fat
e Locus previously reported for childhood obesity
f Independent SNP at the same locus selected by conditional analysis
https://doi.org/10.1371/journal.pgen.1008718.t001
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Fig 2. Locus zoom plots of the 2 novel SNPs Regional association plot of the 2 novel SNPs in the 26 childhood
BMI discovery studies. SNPs are plotted with their P-values (as–log10; left y-axis) as a function of genomic position
(x-axis). Estimated recombination rates (right y-axis) taken from 1000 Genomes, March 2012 release are plotted to
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side of the 25 SNPs. Using this strategy, we additionally found differential expression in liver,
heart, kidney, pancreas, muscle, skin and adipose tissue [31].
Second, we assessed whether the 25 SNPs were associated with gene expression in whole
adipose tissue, isolated adipocytes, and isolated stroma-vascular cells from the Leipzig Adipose
Tissue Childhood Cohort [32]. Full results can be found in S9 Table. We observed differential
gene expression associated with multiple SNPs. Rs1094647 (nearest gene: SLC45A3) was asso-
ciated with gene expression of PM20D1 (PFDR <0.05) in whole adipose tissue. We additionally
found associations of rs114285994 (nearest gene: GPRC5B) with expression of C16orf88 in iso-
lated adipocytes. Rs115181845, which is in moderate LD (r2 = 0.47) with rs144376234 (nearest
gene: GNAI3), was associated with expression of GSTM1 and GSTM2 in whole adipose tissue,
isolated adipocytes and isolated stroma-vascular cells (S8 Table and S9 Table). No associations
with gene expression were observed for any of the other 22 SNPs.
Third, we used Bayesian colocalization analysis to examine evidence for colocalization
between GWAs and eQTL signals and to identify additional candidate genes for the 25 SNPs
(GTEx v7). Briefly, GWAS summary statistics were extracted for each eQTL for all SNPs that
were present in the meta-analysis and that were in common to both GWAS and eQTL studies.
In most pairs, no evidence for association was found with either trait. To define colocalization
we used restriction to pairs of childhood BMI and eQTL signals with a high posterior probabil-
ity for colocalization (See Methods and Materials for details) [33]. We found significant colo-
calizations at 6 loci (ADCY3, DNAJC27-AS1, CENPO, ADAM23, LIN7C, TFAP2B) across a
range of tissues (S8 Table and S10A and S10B Table) [8].
Fourth, to explore biological processes, we used DAVID, with the 25 nearest genes as input,
using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database [34,35]. Pathway anal-
ysis revealed one enriched biological process, cAMP signaling (P-value = 0.03).
Fifth, we performed a look-up in mouse-knockout data of the 25 nearest genes and, addi-
tionally, the genes that were indicated by colocalization and gene expression analysis. Mice in
which NEDD4L was knocked out displayed neuronal abnormalities [36]. No related pheno-
types were shown for SLC45A3 or any of the 4 independent loci (METTL1, PRRC2A,
FAM150B, and MC4R). Of the 19 known loci, ADCY3 showed an association with increased
total body fat in female heterozygous knockout mice, whereas NEGR1 was associated with
decreased lean body mass in male and female homozygous knockout mice (S8 Table). Full
results can be found in S8 Table.
Sixth, among the 25 top SNPs, combined annotation-dependent depletion (CADD) scores
>12.37, indicating potential pathogenicity of a SNP, were observed for rs13107325 (SLC39A8),
rs56133711 (BDNF) and rs17817449 (FTO) (CADD scores of 34, 15.3 and 15.3, respectively)
(S8 Table) [3,37].
Genetic correlations of childhood BMI with adult phenotypes
First, to estimate the SNP heritability and the genetic correlations between childhood BMI and
other traits from external GWAS meta-analysis data, we used LD-score regression [20]. SNP
heritability was 0.23. There were positive genetic correlations of childhood BMI with several
anthropometric and cardio-metabolic traits, including adult BMI (Rg = 0.76, P-
value = 1.45 × 10−112), waist-to-hip ratio (Rg = 0.39, P-value = 1.57 × 10−20), body fat percent-
age (Rg = 0.46, P-value = 7.99 × 10−44), diastolic blood pressure (Rg = 0.11, P-value = 0.002),
type 2 diabetes (Rg = 0.19, P-value = 0.002), and coronary artery disease (Rg = 0.14, P-
reflect the local LD-structure around the top associated SNP (indicated with purple color) and the correlated proxies
(indicated in colors). A. rs1094647 B. rs184566112.
https://doi.org/10.1371/journal.pgen.1008718.g002
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value = 0.001) (Fig 3 and S11 Table). For birth weight, there were positive genetic correlations
with childhood BMI, both when using fetal genetic effects on birth weight and when using
maternal genetic effects on birth weight (Rg = 0.20, P-value = 3.19 x 10
−5 and Rg = 0.12, P-
value = 0.002 for fetal and maternal effects, respectively). Negative genetic correlations were
observed between childhood BMI and total cholesterol (Rg = -0.15, P-value = 0.001), high-den-
sity lipoprotein (HDL) (Rg = -0.22, P-value = 8.65 x 10
−6), and age at menarche (Rg = -0.42, P-
value = 1.03 x 10−32). We did not find genetic correlations with any of the respiratory and neu-
rocognitive phenotypes. Genetic correlations of childhood BMI with a selection of phenotypes
that show evidence of association in observational studies are shown in Fig 3. Full results can
be found in S11 Table.
Second, we did a look-up of the 25 SNPs in the adult BMI GWAS [7]. In total, 12 SNPs and
8 proxy SNPs (r2� 0.87) were available in the adult BMI study comprising ~700,000 individu-
als. No information was available on five loci, FAM150B, GPR1, NEGR1, NEDD4L, and
PRRC2A. The directions of effect of all 20 SNPs were the same in adults as in children. Of
these, 18 were genome-wide significantly associated with adult BMI (P-value <5 x 10−8) and
the other 2 SNPs, SLC45A3 and METTL15, showed suggestive evidence of association (P-
values< 2.1 × 10−6) (S12 Table). Effect sizes of these 20 SNPs for adult BMI were highly corre-
lated with those for childhood BMI (r2 = 0.86).
Third, we calculated a combined childhood BMI genetic risk score (GRS) of the 25
genome-wide significant SNPs, summing the number of BMI-increasing alleles weighted by
their effect sizes from the combined meta-analysis. The GRS was associated with childhood
BMI (P-value = 2.84 × 10−11) in 1,169 children from the Tracking Adolescents’ Individual
Lives Survey (TRAILS) Cohort, aged 7 years, one of the largest replication cohorts (Fig 4). For
each additional average risk allele in the GRS, childhood BMI increased by 0.06 SDS
(SE = 0.009). This GRS explained 3.6% of the variance in childhood BMI. When calculating
the risk score for the TRAILS cohort, effect estimates from the combined meta-analysis were
used after excluding TRAILS from the meta-analysis. We additionally tested the GRS for
Fig 3. Genome-wide genetic correlations between childhood BMI and adult traits and diseases. On the x-axis the
traits and diseases are shown. On the y-axis the genetic correlations (Rg) and corresponding standard errors, indicated
by error bars, between childhood BMI and each trait were shown, estimated by LD score regression. The genetic
correlation estimates (Rg) are colored according to their intensity and direction. Red indicates positive correlation,
blue indicates negative correlation. References can be found in S11 Table.
https://doi.org/10.1371/journal.pgen.1008718.g003
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association with adult BMI in the three sub-cohorts of the Rotterdam Study [38] (RS-I-1;
n = 5,957, RS-II-1; n = 2,147 and RS-III-1; n = 2,998). We found the GRS to be associated with
adult BMI in all study samples (P-values = 5.09 × 10−9, 0.02, and 1.49 × 10−10, respectively).
Per additional average risk allele, adult BMI increased by 0.03 SDS (SE = 0.005), 0.02 SDS
(SE = 0.009) and 0.04 SDS (SE = 0.007), explaining 0.6%, 0.2%, and 1.3% of the variance in
adult BMI, respectively. No association was found of the GRS with birth weight and cardio-
metabolic phenotypes, including insulin, triglycerides, low-density lipoprotein, HDL, total
cholesterol, diastolic blood pressure and systolic blood pressure in 2,831 children aged 6 years
from the Generation R Study if considering a Bonferroni corrected P-value of 0.00625 (S13
Table).
Discussion
In this large GWAS meta-analysis of childhood BMI among >60,000 children aged 2–10
years, we identified 25 genome-wide significant loci. Two of these loci, rs1094647 near
SLC45A3 and rs184566112 near NEDD4L had not been associated with BMI before. We
observed moderate to strong genetic correlations of childhood BMI with several anthropomet-
ric, cardio-metabolic, and endocrinological traits in adulthood, suggesting a shared genetic
background.
Fig 4. Associations of the weighted risk score with childhood BMI. Along the x-axis, categories of the risk score are shown together with the
mean SDS BMI on the y-axis on the right and a line representing the regression of the mean SDS childhood BMI values for each category of the
risk score. Along the y-axis on the left a histogram represents the number of individuals in each risk-score category. P-value is based on the
continuous risk score. Analysis was performed in the TRAILS cohort (N = 1,169).
https://doi.org/10.1371/journal.pgen.1008718.g004
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The closest genes to the two novel loci, SLC45A3 and NEDDL4, have not been strongly
linked to obesity in previous studies and databases, indicating that functional studies are
needed to identify possible biological pathways. SLC45A3, encoding the solute carrier family
45, member 3 protein, also known as prostate cancer-associated protein 6, has been related to
prostate-specific antigen serum concentrations and prostate cancer [39–42]. NEDD4L, ubiqui-
tin protein ligase Nedd4-like, known for its role in the regulation of ion channel internaliza-
tion and turnover, is suggested to play a role in the regulation of respiratory, cardiovascular,
renal, and neuronal functions [36,43–45]. The independent SNPs identified at loci known
from previous studies on adult or childhood BMI may represent fully independent signals,
although due to the low LD, these SNPs might still tag the same causal variant as the previously
identified SNPs.
Since there is no strong previous evidence supporting the closest genes to the 25 SNPs as
the causal genes, we took multiple approaches for further functional characterization. As many
different tissues have been implicated to play a role in body composition we chose to include
all available tissues in the gene expression analysis. Using GTEx, we found differential expres-
sion of the 25 nearest genes in brain. This may be of interest as appetite regulation might play
a role in the development of obesity [46–48]. Gene expression data revealed an association
between one of the novel SNPs, rs1094647 (nearest gene: SLC45A3), and expression of
PM20D1 in whole adipose tissue. PM20D1, Peptidase M20 domain-containing 1, previously
identified as a factor secreted by thermogenic adipose cells, is known for its association with
insulin resistance, glucose intolerance and enhanced defense of body temperature in cold
when knocked out in mice. Furthermore, increased circulating PM20D1, together with adeno-
associated virus-mediated transduction, leads to a higher energy expenditure and reduced adi-
posity in mice [49,50]. We used colocalization analysis to further identify candidate causal
genes. This did not identify specific potential causal genes for rs1094647 (SLC45A3) and
rs184566112 (NEDD4L). However, we identified ADCY3, DNAJC27-AS1, CENPO, ADAM23,
LIN7C, TFAP2B as candidate genes for known loci across different tissues, including tibial
nerve tissue, tibial artery tissue and the skin. No candidate genes were detected in biologically
more relevant tissues, including subcutaneous or visceral adipose tissue.
Information on rs184566112 near NEDD4L was available in 24 out of 26 discovery cohorts
that primarily used 1000 Genomes phase 1 imputed data (N = 37,104), thus clearly surviving
our pre-set filter of having information in at least 50% of the number of studies and at least
50% of the total sample size in the discovery analysis. However, it was available in only less
than half of the replication studies, mainly using 1000 Genomes phase 3 or HRC imputed data
(N = 5,518) as this SNP was not included in these more recent reference panels. No other
SNPs in high LD were available as proxy for this SNP in the replication analysis. Therefore,
this signal needs to be interpreted with caution. However, no heterogeneity of this SNP
between the discovery stage studies (I2 = 0; P-value for heterogeneity = 0.98), a high imputa-
tion quality (weighted mean R2 = 0.89) and the known association of another locus in the
same region with adult body fat percentage might lends credibility to this signal, although fur-
ther work is needed to unravel the details [27]. Previous studies have shown that variants
might have strong age-dependent effects across childhood [15,51]. We performed a sensitivity
analyses excluding children aged<6 years, as the approximate age of the adiposity rebound
[30]. However, no difference in main results with the full meta-analysis were observed.
Observational studies suggest that childhood obesity is not only related to several anthropo-
metric and cardio-metabolic phenotypes in later life, such as type 2 diabetes, but also to respi-
ratory and neurocognitive traits, including asthma and Parkinson’s disease and to a lower age
at menarche [14–18,52–58]. In observational studies, effect estimates may be influenced by
confounding factors and reverse causation, potentially evoking spurious associations [59,60].
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Genetic studies can provide more insight into the etiology of complex diseases. We observed a
strong positive genetic correlation of childhood BMI with adult BMI. This is in line with previ-
ous studies [8,20,21]. We additionally observed positive genetic correlations between child-
hood BMI and several cardio-metabolic phenotypes in later life, including waist-to-hip ratio,
diastolic blood pressure, type 2 diabetes, and coronary artery disease. Negative genetic correla-
tions were found between childhood BMI and HDL-C and age at menarche. These results may
suggest that the associations reported in observational studies are partly explained by genetic
factors [15–17,58,61]. However, there is also evidence from previous work to support that the
associations of childhood BMI with cardiometabolic phenotypes in adulthood are explained
by the continuity of a high BMI from childhood until later ages, rather than by an independent
effect of childhood BMI on adult cardiometabolic phenotypes [15,62]. From our data, we are
not able to distinguish this. Childhood BMI was not genetically correlated with asthma and
Parkinson’s disease. This may indicate that the observational associations between childhood
BMI and these phenotypes are not strongly explained by shared genetics [18,56,57,63].
The GRS combining the 25 top SNPs was not associated with cardiometabolic phenotypes in
children aged 6 years. This may indicate that there is no shared genetic basis between childhood
BMI and these phenotypes in childhood. However, the GRS analyses in children had a much
lower sample size than the LD score regression analyses in adults and phenotypic variation in
these phenotypes is more limited in children, leading to a much lower power to detect associa-
tions in these analyses. Additionally, the GRS was composed of the top-associated SNPs,
whereas the genetic correlation estimated from the LDSR examined variation genome-wide.
We observed a SNP heritability of 0.23 which is consistent with previous findings [4–6].
Secular trends in obesity across populations and age groups can influence the heritability
estimates across distinct population settings, requiring careful interpretation. This contention
is also relevant for the interpretation of the genetic correlations estimated between traits. Envi-
ronmental influences like those giving rise to the increase obesity in the last decades, can influ-
ence heritability estimates and hence, the power to identify significant genetic correlations.
Before concluding unequivocal absence of some degree of “shared heritability” between child-
hood BMI and some of the adult traits, genetic correlations should be interpreted in the con-
text of power limitations. Increasingly larger environmental influences along the life-course
can result in lower heritability, but recent work has also shown that the increase in phenotypic
variance accompanying increasing prevalence of obesity occurs alongside an increase in
genetic variance [64–67]. This results in relatively stable (broad sense) heritability estimates
across measurement years, as recently shown by a large-scale meta-analysis of adult twin data.
The 25-SNP GRS was positively associated with both childhood and adult BMI, showing
slightly larger effect estimates in children suggesting that these specific genetic variants affect
BMI in both childhood and adulthood, but with stronger effects at younger ages. A recent
study, using genome-wide polygenic scores of 2.1 million common variants, found that the
overall effect of those variants on weight starts in early childhood and increases over time [4].
Two previous studies also describe specific genetic variants associated with BMI in infancy
only, and overlapping patterns of genetic variants with those in adults emerging from child-
hood onwards. Three SNPs associated with infant BMI from these studies were not genome-
wide significantly associated with childhood BMI in our data (P-values >0.02), which supports
their infancy-specific effects [68,69].
Although many of the associated variants from the current study overlap between children
and adults, the relative order of the signals differs. Additionally, SLC45A3, one of the novel loci
did not show genome-wide association in adult data [7]. However, suggestive association of
this locus with adult BMI was observed (P-value = 2.7 x 10−5). Overall, the effect estimates of
the 25 SNPs in childhood were highly correlated with those in adulthood (r2 = 0.86). Taken
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together, evidence from the current and previous studies suggests that biological processes
underlying BMI are similar from childhood onwards, but their relative influence may differ
depending on the life stage.
Conclusions
In conclusion, we identified 25 loci for childhood BMI, together explaining 3.6% of the vari-
ance in childhood BMI. Two of these are novel and four represent independent SNPs at loci
known to be associated with adult or childhood BMI. A strong positive genetic correlation of
childhood BMI with adult BMI and related cardio-metabolic phenotypes was observed. Our
results suggest that the biological processes underlying childhood BMI largely, but not
completely, overlap with those underlying adult BMI. The well-known observational associa-
tions of BMI in childhood with cardio-metabolic diseases in adulthood may reflect partial
genetic overlap, but in light of previous evidence, it is also likely that they are explained
through phenotypic continuity of BMI from childhood into adulthood.
Materials and methods
Ethics statement
All individual studies got approval by their medical ethics review committees. All participants
gave written informed consent. Study-specific ethics statements are given in S1 Text.
Study design
We conducted a two-stage meta-analysis in children of European ancestry to identify genetic
loci associated with childhood BMI. Sex- and age-adjusted standard deviation scores were cre-
ated for BMI at the latest time point (oldest age, if multiple measurements were available)
between 2 and 10 years using the same software and external reference across all studies (LMS
growth; Pan H, Cole TJ, 2012; http://www.healthforallchildren.co.uk). In the case of twin pairs
and siblings, only one of each twin or sibling pair was included, either randomly or based on
genotyping or imputation quality.
In the discovery stage, we performed a meta-analysis of 26 studies (N = 39,620), including
the Avon Longitudinal Study of Parents and Children (ALSPAC, N = 6790), the Bone Mineral
Density in Childhood Study (BMDCS, N = 543), BRain dEvelopment and Air polluTion ultra-
fine particles in scHool childrEn (BREATHE, N = 1633), the Children’s Hospital of Philadel-
phia (CHOP, N = 5488), the Copenhagen Prospective Studies on Asthma in Childhood 2000
(COPSAC2000, N = 327), the Copenhagen Prospective Studies on Asthma in Childhood
2010 (COPSAC2010, N = 571), the Danish National Birth Cohort- preterm birth study
(DNBC-PTB, N = 1007), the French Young Study (French young, N = 304 cases and N = 144
controls), the Generation R Study (GenerationR, N = 2071), the Genetics of Overweight
Young Adults (GOYA Male, N = 319), the Helsinki Birth Cohort Study (HBCS, N = 1575), the
INfancia y Medio Ambiente [Environment and Childhood] Project, with two subcohorts that
were entered into the meta-analysis seperately (INMA-Sabadell and Valencia subcohort,
N = 650, and INMA-Menorca subcohort, N = 300), German Infant Study on the influence of
Nutrition Intervention PLUS environmental and genetic influences on allergy development &
Influence of life-style factors on the development of the immune system and allergies in East
and West Germany (GINIplus&LISA, N = 1471), the Manchester Asthma and Allergy Study
(MAAS, N = 784), the Norwegian Mother, Father and Child Cohort (MoBa, N = 522), the
Northern Finland Birth Cohort 1966 (NFBC 1966, N = 3949), the Northern Finland Birth
Cohort 1986 (NFBC 1986, N = 1056), the Netherlands Twin Register (NTR, N = 1767), the
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Physical Activity and Nutrition in Children Study (PANIC, N = 374), The Danish Childhood
Obesity Data and Biobank (TDCOB, N = 158 controls), the Raine Study (the Raine Study
(Generation 2), N = 1458), the Special Turku Coronary Risk factor Intervention Project
(STRIP, N = 551), the Young Finns Study (YFS, N = 1134), the TEENs of Attica: Genes and
Environment (TEENAGE, N = 252), and the British 1958 Birth Cohort Study
(1958BC-T1DGC, N = 2081 and 1958BC-WTCCC, N = 2341).
In the replication stage, we included 14 studies (n = 21,491), which did not have genome-
wide association data available at the time of the discovery analysis: 888 additional children
from the Danish National Birth Cohort- Goya offspring (N = 407 offspring from obese moth-
ers, N = 481 offspring from randomly selected mothers), 294 additional children from the
INfancia y Medio Ambiente [Environment and Childhood] (INMA) Project (INMA- Gipuz-
koa subcohort, N = 314), 6,828 additional children from the Norwegian Mother, Father and
Child Cohort (MoBa, N = 6828), 753 additional children from TDCOB (N = 344 controls and
N = 409 cases), the Amsterdam Born Children and their Development- Genetic Enrichment
(ABCD, N = 1154), The European Childhood Obesity Project (CHOP Study, N = 369), the
Family Atherosclerosis Monitoring In earLY life (FAMILY) study (the FAMILY study,
N = 543), the Etude des Déterminants pré- et postnatals précoces du développement et de la
santé de l’Enfant (EDEN) mother-child cohort (EDEN, N = 821), the Exeter Family Study of
Childhood Health (EFSOCH, N = 542), the Leipzig Research Center for Civilization Diseases
—Child study (LIFE-Child, N = 1318), the Prevention and Incidence of Asthma and Mite
Allergy study (PIAMA, N = 1958), the Screening of older women for prevention of fracture
Study (SCOOP, N = 685), the Småbørns Kost Og Trivsel study (SKOT1, N = 236), the Twin
Early Development Study (TEDS, N = 3933), the Tracking Adolescents’ Individual Lives Sur-
vey cohort (TRAILS-population cohort, N = 1169). In the EDEN mother-child cohort, infor-
mation was available about three SNPs only (rs7138803, rs13107325, and rs987237).
Characteristics of discovery and replication studies can be found in S1 Table and S1 Text.
Study-level analyses
Genome-wide association analyses were first run in all discovery cohorts separately. Studies
used high-density Illumina or Affymetrix SNP arrays, followed by imputation to the 1000
Genomes Project or HRC. Before imputation, studies applied study specific quality filters on
sample and SNP call rate, minor allele frequency and Hardy–Weinberg disequilibrium (see S1
Table for details). Linear regression models assuming an additive genetic model were run in
each study to assess the association of each SNP with BMI SDS, adjusting for principal compo-
nents if this was deemed needed in the individual studies. As BMI SDS is age and sex specific,
no further adjustments were made. Before the meta-analysis, we applied quality filters to each
study, filtering out SNPs with a minor allele frequency (MAF) below 1% and SNPs with poor
imputation quality (MACH r2_hat�0.3, IMPUTE proper_info�0.4 or info�0.4).
Meta-analysis
We performed fixed-effects inverse-variance weighted meta-analysis of all discovery samples
using Metal [70]. Genomic control was applied to every study before the meta-analysis. Indi-
vidual study lambdas before genomic control ranged from 0.993 to 1.036 (S1 Table). The
lambda of the discovery meta-analysis is shown in S1 Fig. After the meta-analysis, we excluded
SNPs for which information was available in less than 50% of the studies and less than 50% of
the total sample size. We report I2 and p-value for heterogeneity for all findings.
The final dataset consisted of 8,228,795 autosomal SNPs. Genome-wide Complex Trait
Analysis (GCTA) was used to select the independent SNPs for each locus [22]. We performed
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conditional analyses based on summary-level statistics and LD estimation between SNPs from
the Generation R Study as a reference sample to select independently associated SNPs based
on conditional P-values [22]. Forty-seven genome-wide significant or suggestive loci (P-values
<5 × 10−8 and <5 × 10−6, respectively) were taken forward for replication in 14 replication
cohorts. Fixed-effects inverse variance meta-analysis was performed for these 47 SNPs com-
bining the discovery samples and all replication samples, giving a combined analysis beta, stan-
dard error and P-value (Table 1). SNPs that reached genome-wide significance in the
combined analysis were considered to be genome-wide significant.
Functional mapping and annotation of genetic associations (FUMA)
To obtain predicted functional consequences for our 25 SNPs, we used SNP2FUNC in FUMA,
a web-based platform to facilitate and visualize functional annotation of GWAS results (http://
fuma.ctglab.nl) [3]. By matching chromosome, position, and reference and alternative alleles,
combined annotation-dependent depletion (CADD) scores were annotated, indicating the del-
eteriousness of a SNP [37].
To annotate the nearest genes of the 25 SNPs in biological context, we used the GENE2-
FUNC option in FUMA, which provides hypergeometric tests of enrichment of a list of genes
in 53 GTEx tissue-specific gene expression sets (GTEx v 7) [3,31]. We used GENE2FUNC for
two sets of genes: 1. Nearest genes of 25 SNPs; 2. Genes located in a region of 500 kb to either
side of the 25 SNPs.
Look-up of the 25 SNPs in expression data
We studied the associations of the 25 SNPs associated with childhood BMI with gene expres-
sion levels in adipose tissue samples from the Leipzig Adipose Tissue Childhood Cohort [32].
These associations were examined in the following tissues: whole adipose tissue, isolated adi-
pocytes and isolated stroma-vascular cells using genome- wide expression analysis (Illumina
HumanHT-12 v4 arrays). Gene expression raw data of all 47,231 probes was extracted by Illu-
mina GenomeStudio without additional background correction. Data was further processed
within R / Bioconductor. Expression values were log2-transformed and quantile-normalised
[71,72]. Batch effects of expression BeadChips were corrected using an empirical Bayes
method [73].Within pre-processing, gene-expression probes detected by Illumina GenomeS-
tudio as expressed in less than 5% of the samples were excluded as well as probes still found to
be significantly associated with batch effects after Bonferroni-correction. Furthermore, gene-
expression probes with poor mapping on the human trancriptome [74] were also excluded. In
summary, these filters resulted in 23354, 21258, and 22637 valid gene-expression probes from
which 20672, 18956, and 20230 probes corresponded to 14455, 13518, and 14256 genes map-
ping to a unique position in the human genome (hg19) for whole adipose tissue, adipocytes,
and stroma/vascular cells, respectively. Three criteria were used to remove samples of low
quality: First, the number of detected gene-expression probes of a sample was required to be
within ± 3 interquartile ranges (IQR) from the median. Second, the Mahalanobis distance of
several quality characteristics of each sample had to be lower than median + 4 x IQR. Third,
Euclidean distances of expression values as described [71] had to be lower than median + 4 x
IQR. Overall, of the assayed samples, 2, 4, and 2 samples were excluded for quality reasons
leaving 203, 63 and 69 unique individuals having also valid data for eQTL analysis for whole
adipose tissue, adipocytes, and stroma/vascular cells, respectively. Associations between the
genotype and gene expression of genes in cis (respective gene area +/- 1 Mb regarding tran-
scription start and transcription end) were analyzed using a gene-dose based linear regression
model adjusted for age and sex as implemented in MatrixEQTL [75]. Analysis of variants
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within one haplotype were done through analyses of linkage-disequilibrium using 1000
Genomes Phase 1 Version 3 and HapMap r28 hg19 CEU as references.
Colocalization analysis
We used Bayesian colocalization analysis to examine evidence for colocalization between
childhood BMI and eQTL signals (GTEx v7).Colocalization analyses were conducted using the
R package coloc, hht://cran.r-project.org/web/packages/coloc, as described previously [33].
Briefly, in each of the GTEx v7 tissues, all cis-eQTLs at FDR<5% were identified. For each
eQTL, GWAS summary statistics were extracted for all SNPs that were present in >50% of the
studies and>50% of the total sample size and that were in common to both GWAS and eQTL
studies, within 1 MB of the transcription start site of the gene. For each such locus, colocaliza-
tion analyses were done with default parameters, testing the following hypotheses [33]:
H0: No association with either trait;
H1: Association with childhood BMI only;
H2: Association with gene expression only;
H3: Association with childhood BMI and gene expression, two distinct causal variants;
H4: Association with childhood BMI and gene expression, one shared causal variant.
Support for each hypothesis was quantified in terms of posterior probabilities, defined at
SNP level and indicated by PP0, PP1, PP2, PP3 or PP4, corresponding to the five hypotheses
and measuring how likely these hypotheses were. S10B Table shows the above-mentioned pos-
terior probabilities for all pairs. In most pairs, no evidence for association was found with
either trait. In case association was observed, it was mostly with a single trait. To define coloca-
lization we used restriction to pairs of childhood BMI and eQTL signals with a high posterior
probability for colocalization, indicated by a PP4/(PP3+PP4) >0.9 (S10A Table).
DAVID
To explore biological processes, we used DAVID, with the 25 nearest genes as input, using the
Kyoto Encyclopedia of Genes and Genomes (KEGG) database [34,35].
Linkage-disequilibrium score regression
The use of LD score regression to estimate genetic correlations between two phenotypes has
been described in detail previously [20]. Briefly, LD score is a measure of how much a genetic
variation is tagged by each variant. A high LD score indicates that a variant is in high LD with
many nearby polymorphisms. Variants with high LD scores are more likely to contain true sig-
nals and have a higher chance of overlap with genuine signals between GWAS. To estimate LD
scores, summary statistics from GWAS meta-analysis are used to calculate the cross-product
of test statistics per SNP, which is regressed on the LD score. The slope of the regression is a
function of the genetic covariance between traits [20]:
E z1jz2jð Þ ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
N1N2rg
p
M
ljþ
rNs
ffiffiffiffiffiffiffiffiffiffiffiffiffi
N1N2
p
where Ni is the sample size of study i, ρg is the genetic covariance, M is the number of SNPs in
the reference panel with a MAF between 5% and 50%, lj is the LD score for SNP j, Ns quantifies
the number of individuals that overlap both studies, and ρ is the phenotypic correlation
amongst the Ns of overlapping samples. A sample overlap or cryptic relatedness between
PLOS GENETICS Genetic background of childhood body mass index
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008718 October 12, 2020 18 / 26
samples will only affect the intercept from the regression but not the slope. Estimates of genetic
covariance will therefore not be biased by overlapping samples. Similarly, in case of population
stratification, the intercept will be affected but it will have only minimal impact on the slope
since population stratification does not correlate with LD between variants.
Because of the correlation between the imputation quality and LD score, imputation quality
is a confounder for LD score regression. Therefore, SNPs were excluded for the following rea-
sons: MAF <0.01 and INFO�0.9. The filtered GWAS results were uploaded on http://ldsc.
broadinstitute.org/ldhub/, a website with many GWAS meta-analyses available on which LD
score regression has been implemented by the developers of the LD score regression method.
In case multiple GWAS meta-analyses were available for the same phenotype, the genetic cor-
relation with childhood BMI was estimated using the most recent meta-analysis. Genetic cor-
relations are shown in Fig 2 and S11 Table.
Genetic risk score and percentage of variance explained
We combined the 25 genome-wide significant SNPs from the combined meta-analysis into a
GRS by summing up the number of BMI SDS-increasing alleles, weighted by the effect sizes
from the combined meta-analysis. The GRS was rescaled to a range from 0 to 50, which is the
maximum number of BMI SDS increasing alleles and rounded to the nearest integer. Linear
regression analysis was used to examine the associations of the risk score with childhood and
adult BMI. For these analyses data from the TRAILS cohort (N = 1169), one of the largest rep-
lication cohorts, and data from the Rotterdam Study (RS-I-1; n = 5,957, RS-II-1; n = 2,147 and
RS-III-1; n = 2,998) were used. Additionally, linear regression analysis was used to examine
the associations of the GRS with birth weight and childhood metabolic phenotypes in Genera-
tion R in which detailed information on these phenotypes was available. When calculating the
risk score for the TRAILS cohort and Generation R, effect estimates from the combined meta-
analysis were used after excluding TRAILS and Generation R, respectively, from the meta-
analysis. The variance explained was estimated by the adjusted R2 of the models.
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G. Uitterlinden, Catharina E. M. van Beijsterveldt, Marc Vaudel, Elvira Verduci, Rebecca
K. Vinding, Mandy Vogel, Eleftheria Zeggini, Sylvain Sebert, Mads V. Lind, Loreto Santa-
Marina, Eva Reischl, Christine Frithioff-Bøjsøe, David Meyre, Eleanor Wheeler, Ken Ong,
Ellen A. Nohr, Tanja G. M. Vrijkotte, Robert Plomin, Pål R. Njølstad, George D. Dedoussis,
Thorkild I. A. Sørensen, Rachel M. Freathy, Babette S. Zemel, Olli Raitakari, Martine Vrij-
heid, Bjarke Feenstra, Harold Snieder, Patrick G. Holt, Joachim Heinrich, Elisabeth Widén,
Jordi Sunyer, Marjo-Riitta Järvelin, Antje Körner, George Davey Smith, Jens-Christian
Holm, Mustafa Atalay, Clare Murray, Hans Bisgaard, Mark I. McCarthy, Vincent W. V.
Jaddoe, Struan F. A. Grant, Janine F. Felix.
Formal analysis: Suzanne Vogelezang, Jonathan P. Bradfield, Tarunveer S. Ahluwalia, John A.
Curtin, Niels Grarup, Markus Scholz, Peter J. van der Most, Claire Monnereau, Evie Ster-
giakouli, Anni Heiskala, Momoko Horikoshi, Iryna O. Fedko, Natalia Vilor-Tejedor, Diana
L. Cousminer, Carol A. Wang, Frank Geller, Niina Pitkänen, Alessandra Chesi, Loic Yengo,
Ioanna Ntalla, Øyvind Helgeland, Saskia Selzam, Judith M. Vonk, Mohammed H. Zafar-
mand, Barbara Heude, Akram Alyass, Robin N. Beaumont, Christian T. Have, Peter Rze-
hak, Jose Ramon Bilbao, Theresia M. Schnurr, Lisbeth Carstensen, Maria Groen-Blokhuis,
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